DK1004583T3 - Fremgangsmåde og hydantoinmellemprodukter til syntesen af væksthormonsekretagoger - Google Patents

Fremgangsmåde og hydantoinmellemprodukter til syntesen af væksthormonsekretagoger

Info

Publication number
DK1004583T3
DK1004583T3 DK99309203T DK99309203T DK1004583T3 DK 1004583 T3 DK1004583 T3 DK 1004583T3 DK 99309203 T DK99309203 T DK 99309203T DK 99309203 T DK99309203 T DK 99309203T DK 1004583 T3 DK1004583 T3 DK 1004583T3
Authority
DK
Denmark
Prior art keywords
synthesis
growth hormone
hormone secretagogues
hydantoin intermediates
hydantoin
Prior art date
Application number
DK99309203T
Other languages
English (en)
Inventor
Charles Kwok-Fung Chiu
David Andrew Griffith
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1004583T3 publication Critical patent/DK1004583T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D247/00—Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99309203T 1998-11-23 1999-11-18 Fremgangsmåde og hydantoinmellemprodukter til syntesen af væksthormonsekretagoger DK1004583T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10952498P 1998-11-23 1998-11-23

Publications (1)

Publication Number Publication Date
DK1004583T3 true DK1004583T3 (da) 2004-12-13

Family

ID=22328134

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99309203T DK1004583T3 (da) 1998-11-23 1999-11-18 Fremgangsmåde og hydantoinmellemprodukter til syntesen af væksthormonsekretagoger

Country Status (20)

Country Link
US (4) US6297380B1 (da)
EP (1) EP1004583B1 (da)
JP (2) JP3488155B2 (da)
KR (1) KR20000035568A (da)
CN (1) CN1255498A (da)
AR (1) AR019498A1 (da)
AT (1) ATE274517T1 (da)
AU (1) AU5958499A (da)
BR (1) BR9905732A (da)
CA (1) CA2290252C (da)
DE (1) DE69919663T2 (da)
DK (1) DK1004583T3 (da)
ES (1) ES2226297T3 (da)
HU (1) HUP9904384A3 (da)
ID (1) ID23852A (da)
IL (1) IL133043A0 (da)
PL (1) PL336710A1 (da)
PT (1) PT1004583E (da)
TR (1) TR199902879A2 (da)
ZA (1) ZA997227B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058947A1 (en) * 1997-06-25 1998-12-30 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
US6297380B1 (en) 1998-11-23 2001-10-02 Pfizer Inc. Process and intermediates for growth hormone secretagogues
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6710064B2 (en) 2000-12-01 2004-03-23 Bristol-Myers Squibb Co. Hydantoin compounds useful as anti-inflammatory agents
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2003011824A1 (en) 2001-07-31 2003-02-13 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US7087636B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
US7405234B2 (en) 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
WO2004045518A2 (en) 2002-11-15 2004-06-03 Bristol-Myers Squibb Company Open chain prolyl urea-related modulators of androgen receptor function
US7820702B2 (en) 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7625923B2 (en) 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
ES2690205T3 (es) * 2006-04-13 2018-11-19 Neurotech Pharmaceuticals Co., Ltd. Composición farmacéutica para tratar o prevenir enfermedades inflamatorias
EP2039695A4 (en) * 2006-07-11 2010-09-15 Takeda Pharmaceutical BICYCLIC HETEROCYLIC COMPOUND AND ITS USE
IL300309B2 (en) * 2020-08-12 2026-03-01 Genentech Inc Synthesis of quinazoline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746755A (en) 1986-05-06 1988-05-24 The Dow Chemical Company Preparation of hydrantoic acids and hydantoins
DE3643748A1 (de) 1986-12-20 1988-06-30 Hoechst Ag Bicylische imide, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz
US4868061A (en) 1988-05-19 1989-09-19 The Standard Oil Company Olefinic aryl oxime derivatives of hydantoins
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
GB2324087A (en) * 1997-04-10 1998-10-14 Merck & Co Inc Preparation of (S)-3-Carbethoxy-3-benzylpiperidine
WO1998058947A1 (en) * 1997-06-25 1998-12-30 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
US6358951B1 (en) * 1998-08-21 2002-03-19 Pfizer Inc. Growth hormone secretagogues
US6297380B1 (en) 1998-11-23 2001-10-02 Pfizer Inc. Process and intermediates for growth hormone secretagogues

Also Published As

Publication number Publication date
US6686471B2 (en) 2004-02-03
US20030225280A1 (en) 2003-12-04
ATE274517T1 (de) 2004-09-15
AU5958499A (en) 2000-05-25
HUP9904384A2 (hu) 2000-08-28
CN1255498A (zh) 2000-06-07
US20030088097A1 (en) 2003-05-08
CA2290252C (en) 2004-08-24
DE69919663T2 (de) 2005-09-01
JP3488155B2 (ja) 2004-01-19
JP2003012672A (ja) 2003-01-15
PL336710A1 (en) 2000-06-05
ZA997227B (en) 2001-05-22
PT1004583E (pt) 2004-12-31
US6297380B1 (en) 2001-10-02
BR9905732A (pt) 2001-03-20
EP1004583A3 (en) 2000-06-14
DE69919663D1 (de) 2004-09-30
EP1004583A2 (en) 2000-05-31
EP1004583B1 (en) 2004-08-25
US20020010335A1 (en) 2002-01-24
US6465651B2 (en) 2002-10-15
US6603002B2 (en) 2003-08-05
ID23852A (id) 2000-05-25
HUP9904384A3 (en) 2002-04-29
HU9904384D0 (en) 2000-01-28
JP2000159770A (ja) 2000-06-13
AR019498A1 (es) 2002-02-20
IL133043A0 (en) 2001-03-19
KR20000035568A (ko) 2000-06-26
TR199902879A2 (xx) 2000-06-21
CA2290252A1 (en) 2000-05-23
ES2226297T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
DK1004583T3 (da) Fremgangsmåde og hydantoinmellemprodukter til syntesen af væksthormonsekretagoger
FI974368A7 (fi) Kasvuhormonin vapautumista edistäviä dipeptidejä
DK0922040T3 (da) Fremgangsmåde til fremstilling af mellemprodukter til florfenicol
DK0518521T3 (da) Foringselement til foring af forgreningsrør og fremgangsmåde til fremstilling heraf
DK0773940T4 (da) Fremgangsmåde til syntese af substituerede sulfoxider
EE200000642A (et) Suurendatud saagisega FAPalfa-spetsiifilised antikehad
NO20001994L (no) FremgangsmÕte for sporing av atmosfæriske værforhold
IL154111A0 (en) Synthesis of intermediates for the preparation of growth hormone secretagogues
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK0831098T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af olanzapin
DK0937068T3 (da) Fremgangsmåde til krystallisation af losartan
DK1039888T3 (da) Fremgangsmåde til forøgelse af produktionen og forbedring af kvaliteten af sæd
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0912107T3 (da) Fremgangsmåde til reducering af nedbrydeligheden af dyrefoderprotein
IT1295934B1 (it) Procedimento migliorato per la sintesi di alchilpoliglucosidi
DK0842930T3 (da) Fremgangsmåde til syntese af benzothiophener
DK1023292T3 (da) Fremgangsmåde til syntese af chlorpurinintermediater
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
DK0981349T3 (da) 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK1023279T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
SI1004583T1 (en) Process and hydantoin intermediates for the synthesis of growth hormone secretagogues
DK1031565T3 (da) Hidtil ukendte krystaller af depsipeptidderivat og fremgangsmåde til fremstilling heraf
DK0930297T3 (da) Fremgangsmåde til fremstilling af naphtyridoner og mellemprodukter
DK1073627T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter